N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142820 |
| CAS No | NA |
| Mol.F. | C10H16BN3O7S3 |
| Mol.Wt. | 397.24g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142821 |
| CAS No | NA |
| Mol.F. | C20H27N4O9S6 |
| Mol.Wt. | 659.82 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142822 |
| CAS No | NA |
| Mol.F. | C20H28N4O9S6 |
| Mol.Wt. | 660.82 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142823 |
| CAS No | NA |
| Mol.F. | C10H15N3O5S3 |
| Mol.Wt. | 353.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142824 |
| CAS No | NA |
| Mol.F. | C10H15N3O5S3 |
| Mol.Wt. | 353.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142825 |
| CAS No | NA |
| Mol.F. | C14H19N3O9S3 |
| Mol.Wt. | 469.50 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142826 |
| CAS No | NA |
| Mol.F. | C20H28N4O9S6 |
| Mol.Wt. | 660.82 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142827 |
| CAS No | 3028193-50-9 |
| Mol.F. | C20H20N2O2 |
| Mol.Wt. | 320.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142828 |
| CAS No | NA |
| Mol.F. | C18H24N4O6S2 |
| Mol.Wt. | 456.53g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142829 |
| CAS No | NA |
| Mol.F. | C20H28N4O8S3 |
| Mol.Wt. | 548.64 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142830 |
| CAS No | NA |
| Mol.F. | C20H28N4O8S3 |
| Mol.Wt. | 548.64 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142831 |
| CAS No | NA |
| Mol.F. | C10H165N3O4S |
| Mol.Wt. | 273.31g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142832 |
| CAS No | NA |
| Mol.F. | C24H23ClN2O2 |
| Mol.Wt. | 406.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142833 |
| CAS No | NA |
| Mol.F. | C22H24N4O8S |
| Mol.Wt. | 504.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142834 |
| CAS No | NA |
| Mol.F. | C23H24N4O10S |
| Mol.Wt. | 548.52g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142835 |
| CAS No | NA |
| Mol.F. | C22H26N4O9S |
| Mol.Wt. | 522.53 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |